A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque Psoriasis
- First Posted Date
- 2018-08-15
- Last Posted Date
- 2020-07-29
- Lead Sponsor
- Escalier Biosciences B.V.
- Target Recruit Count
- 104
- Registration Number
- NCT03630939
- Locations
- 🇺🇸
Study Site 14, Raleigh, North Carolina, United States
🇺🇸Study Site 18, San Antonio, Texas, United States
🇺🇸Study Site 15, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath